{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T16:27:49Z","timestamp":1785256069970,"version":"3.55.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,21]],"date-time":"2022-09-21T00:00:00Z","timestamp":1663718400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,9,21]],"date-time":"2022-09-21T00:00:00Z","timestamp":1663718400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81071851"],"award-info":[{"award-number":["81071851"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81001189"],"award-info":[{"award-number":["81001189"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81602645"],"award-info":[{"award-number":["81602645"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81902828"],"award-info":[{"award-number":["81902828"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82003066"],"award-info":[{"award-number":["82003066"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82002928"],"award-info":[{"award-number":["82002928"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2016A030313768"],"award-info":[{"award-number":["2016A030313768"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2018A030313292"],"award-info":[{"award-number":["2018A030313292"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Medical scientific research foundation of Guangdong province","award":["A2020025"],"award-info":[{"award-number":["A2020025"]}]},{"name":"Medical scientific research foundation of Guangdong province","award":["B2019039"],"award-info":[{"award-number":["B2019039"]}]},{"DOI":"10.13039\/501100010256","name":"Guangzhou municipal science and technology project","doi-asserted-by":"crossref","award":["201707010418"],"award-info":[{"award-number":["201707010418"]}],"id":[{"id":"10.13039\/501100010256","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100010256","name":"Guangzhou municipal science and technology project","doi-asserted-by":"crossref","award":["201804010430"],"award-info":[{"award-number":["201804010430"]}],"id":[{"id":"10.13039\/501100010256","id-type":"DOI","asserted-by":"crossref"}]},{"name":"China Anti-Cancer Association-HER2 Target China Scientific Research Fund","award":["CORP-239-S24"],"award-info":[{"award-number":["CORP-239-S24"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1007\/s12282-022-01400-x","type":"journal-article","created":{"date-parts":[[2022,9,21]],"date-time":"2022-09-21T04:02:45Z","timestamp":1663732965000},"page":"77-87","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Single-cell profile of tumor and immune cells in primary breast cancer, sentinel lymph node, and metastatic lymph node"],"prefix":"10.1007","volume":"30","author":[{"given":"Ning","family":"Liao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheukfai","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chongyang","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsiaopei","family":"Mok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingzhu","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuchen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingzi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaoyi","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangrong","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuting","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongrui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6048-405X","authenticated-orcid":false,"given":"Wendy","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles M.","family":"Balch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armando E.","family":"Giuliano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,21]]},"reference":[{"issue":"1","key":"1400_CR1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/tbj.13729","volume":"26","author":"AE Giuliano","year":"2020","unstructured":"Giuliano AE. The evolution of sentinel node biopsy for breast cancer: personal experience. Breast J. 2020;26(1):17\u201321.","journal-title":"Breast J"},{"issue":"10","key":"1400_CR2","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1001\/jama.2017.11470","volume":"318","author":"AE Giuliano","year":"2017","unstructured":"Giuliano AE, Ballman KV, McCall L, et al. Effect of axillary dissection vs no axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis: The ACOSOG Z0011 (Alliance) randomized clinical trial. JAMA. 2017;318(10):918\u201326.","journal-title":"JAMA"},{"issue":"3","key":"1400_CR3","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1097\/00000658-199509000-00016","volume":"222","author":"AE Giuliano","year":"1995","unstructured":"Giuliano AE, Dale PS, Turner RR, et al. Improved axillary staging of breast cancer with sentinel lymphadenectomy. Ann Surg. 1995;222(3):394\u20139 (discussion 399\u2013401).","journal-title":"Ann Surg"},{"issue":"3","key":"1400_CR4","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1097\/00000658-199409000-00015","volume":"220","author":"AE Giuliano","year":"1994","unstructured":"Giuliano AE, Kirgan DM, Guenther JM, et al. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg. 1994;220(3):391\u20138 (discussion 398\u2013401).","journal-title":"Ann Surg"},{"issue":"4","key":"1400_CR5","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1001\/archsurg.1992.01420040034005","volume":"127","author":"DL Morton","year":"1992","unstructured":"Morton DL, Wen DR, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg. 1992;127(4):392\u20139.","journal-title":"Arch Surg"},{"issue":"5","key":"1400_CR6","doi-asserted-by":"publisher","first-page":"484","DOI":"10.6004\/jnccn.2021.0023","volume":"19","author":"WJ Gradishar","year":"2021","unstructured":"Gradishar WJ, Moran MS, Abraham J, et al. NCCN Guidelines(R) Insights: Breast Cancer, Version 4.2021. J Natl Compr Canc Netw. 2021;19(5):484\u201393.","journal-title":"J Natl Compr Canc Netw"},{"issue":"10","key":"1400_CR7","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/S1470-2045(10)70207-2","volume":"11","author":"DN Krag","year":"2010","unstructured":"Krag DN, Anderson SJ, Julian TB, et al. Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol. 2010;11(10):927\u201333.","journal-title":"Lancet Oncol"},{"issue":"9","key":"1400_CR8","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1093\/jnci\/djj158","volume":"98","author":"RE Mansel","year":"2006","unstructured":"Mansel RE, Fallowfield L, Kissin M, et al. Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial. J Natl Cancer Inst. 2006;98(9):599\u2013609.","journal-title":"J Natl Cancer Inst"},{"key":"1400_CR9","doi-asserted-by":"publisher","first-page":"15081","DOI":"10.1038\/ncomms15081","volume":"8","author":"W Chung","year":"2017","unstructured":"Chung W, Eum HH, Lee HO, et al. Single-cell RNA-seq enables comprehensive tumour and immune cell profiling in primary breast cancer. Nat Commun. 2017;8:15081.","journal-title":"Nat Commun"},{"issue":"1","key":"1400_CR10","doi-asserted-by":"publisher","first-page":"3588","DOI":"10.1038\/s41467-018-06052-0","volume":"9","author":"M Karaayvaz","year":"2018","unstructured":"Karaayvaz M, Cristea S, Gillespie SM, et al. Unravelling subclonal heterogeneity and aggressive disease states in TNBC through single-cell RNA-seq. Nat Commun. 2018;9(1):3588.","journal-title":"Nat Commun"},{"issue":"5","key":"1400_CR11","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/j.cell.2018.05.060","volume":"174","author":"E Azizi","year":"2018","unstructured":"Azizi E, Carr AJ, Plitas G, et al. Single-cell map of diverse immune phenotypes in the breast tumor microenvironment. Cell. 2018;174(5):1293\u2013308.","journal-title":"Cell"},{"issue":"4","key":"1400_CR12","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/j.cell.2018.03.041","volume":"173","author":"C Kim","year":"2018","unstructured":"Kim C, Gao R, Sei E, et al. Chemoresistance evolution in triple-negative breast cancer delineated by single-cell sequencing. Cell. 2018;173(4):879\u201393.","journal-title":"Cell"},{"issue":"5","key":"1400_CR13","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1016\/j.cell.2019.03.005","volume":"177","author":"J Wagner","year":"2019","unstructured":"Wagner J, Rapsomaniki MA, Chevrier S, et al. A single-cell atlas of the tumor and immune ecosystem of human breast cancer. Cell. 2019;177(5):1330\u201345.","journal-title":"Cell"},{"issue":"7796","key":"1400_CR14","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1038\/s41586-019-1876-x","volume":"578","author":"HW Jackson","year":"2020","unstructured":"Jackson HW, Fischer JR, Zanotelli VRT, et al. The single-cell pathology landscape of breast cancer. Nature. 2020;578(7796):615\u201320.","journal-title":"Nature"},{"issue":"4","key":"1400_CR15","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1245\/s10434-008-9815-3","volume":"15","author":"TE Becker","year":"2008","unstructured":"Becker TE, Ellsworth RE, Deyarmin B, et al. The genomic heritage of lymph node metastases: implications for clinical management of patients with breast cancer. Ann Surg Oncol. 2008;15(4):1056\u201363.","journal-title":"Ann Surg Oncol"},{"issue":"12","key":"1400_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0115346","volume":"9","author":"K Blighe","year":"2014","unstructured":"Blighe K, Kenny L, Patel N, et al. Whole genome sequence analysis suggests intratumoral heterogeneity in dissemination of breast cancer to lymph nodes. PLoS ONE. 2014;9(12): e115346.","journal-title":"PLoS ONE"},{"issue":"3","key":"1400_CR17","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s00418-019-01802-7","volume":"152","author":"A Gibert-Ramos","year":"2019","unstructured":"Gibert-Ramos A, Lopez C, Bosch R, et al. Immune response profile of primary tumour, sentinel and non-sentinel axillary lymph nodes related to metastasis in breast cancer: an immunohistochemical point of view. Histochem Cell Biol. 2019;152(3):177\u201393.","journal-title":"Histochem Cell Biol"},{"key":"1400_CR18","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.9779","volume":"8","author":"C Lopez","year":"2020","unstructured":"Lopez C, Bosch-Princep R, Orero G, et al. Peritumoral immune infiltrates in primary tumours are not associated with the presence of axillary lymph node metastasis in breast cancer: a retrospective cohort study. PeerJ. 2020;8: e9779.","journal-title":"PeerJ"},{"issue":"3","key":"1400_CR19","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.ajpath.2020.11.008","volume":"191","author":"C Lopez","year":"2021","unstructured":"Lopez C, Gibert-Ramos A, Bosch R, et al. Differences in the immune response of the nonmetastatic axillary lymph nodes between triple-negative and luminal A breast cancer surrogate subtypes. Am J Pathol. 2021;191(3):545\u201354.","journal-title":"Am J Pathol"},{"issue":"5","key":"1400_CR20","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1159\/000492435","volume":"13","author":"F Peintinger","year":"2018","unstructured":"Peintinger F, Reitsamer R, Smidt ML, et al. Lymph Nodes in Breast Cancer - What Can We Learn from Translational Research? Breast Care (Basel). 2018;13(5):342\u20137.","journal-title":"Breast Care (Basel)"},{"issue":"11","key":"1400_CR21","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1038\/s41422-019-0228-6","volume":"29","author":"Y Zeng","year":"2019","unstructured":"Zeng Y, He J, Bai Z, et al. Tracing the first hematopoietic stem cell generation in human embryo by single-cell RNA sequencing. Cell Res. 2019;29(11):881\u201394.","journal-title":"Cell Res"},{"issue":"7","key":"1400_CR22","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1016\/j.cell.2019.05.031","volume":"177","author":"T Stuart","year":"2019","unstructured":"Stuart T, Butler A, Hoffman P, et al. Comprehensive integration of single-cell data. Cell. 2019;177(7):1888\u2013902.","journal-title":"Cell"},{"issue":"4","key":"1400_CR23","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.cels.2018.11.005","volume":"8","author":"SL Wolock","year":"2019","unstructured":"Wolock SL, Lopez R, Klein AM. Scrublet: computational identification of cell doublets in single-cell transcriptomic data. Cell Syst. 2019;8(4):281\u201391.","journal-title":"Cell Syst"},{"issue":"4","key":"1400_CR24","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/nbt.2859","volume":"32","author":"C Trapnell","year":"2014","unstructured":"Trapnell C, Cacchiarelli D, Grimsby J, et al. The dynamics and regulators of cell fate decisions are revealed by pseudotemporal ordering of single cells. Nat Biotechnol. 2014;32(4):381\u20136.","journal-title":"Nat Biotechnol"},{"issue":"2","key":"1400_CR25","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s12539-019-00357-4","volume":"12","author":"X Zhu","year":"2020","unstructured":"Zhu X, Zhang J, Xu Y, et al. Single-cell clustering based on shared nearest neighbor and graph partitioning. Interdiscip Sci. 2020;12(2):117\u201330.","journal-title":"Interdiscip Sci"},{"issue":"1","key":"1400_CR26","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.ygeno.2017.08.007","volume":"110","author":"B Zhao","year":"2018","unstructured":"Zhao B, Erwin A, Xue B. How many differentially expressed genes: a perspective from the comparison of genotypic and phenotypic distances. Genomics. 2018;110(1):67\u201373.","journal-title":"Genomics"},{"key":"1400_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2021.103542","volume":"71","author":"B Chen","year":"2021","unstructured":"Chen B, Zhang G, Lai J, et al. Genetic and immune characteristics of sentinel lymph node metastases and multiple lymph node metastases compared to their matched primary breast tumours. EBioMedicine. 2021;71: 103542.","journal-title":"EBioMedicine"},{"issue":"5","key":"1400_CR28","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nmeth.3337","volume":"12","author":"AM Newman","year":"2015","unstructured":"Newman AM, Liu CL, Green MR, et al. Robust enumeration of cell subsets from tissue expression profiles. Nat Methods. 2015;12(5):453\u20137.","journal-title":"Nat Methods"},{"issue":"7","key":"1400_CR29","doi-asserted-by":"publisher","first-page":"2750","DOI":"10.1172\/JCI45014","volume":"121","author":"BD Lehmann","year":"2011","unstructured":"Lehmann BD, Bauer JA, Chen X, et al. Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies. J Clin Invest. 2011;121(7):2750\u201367.","journal-title":"J Clin Invest"},{"issue":"1","key":"1400_CR30","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.immuni.2014.06.010","volume":"41","author":"R Noy","year":"2014","unstructured":"Noy R, Pollard JW. Tumor-associated macrophages: from mechanisms to therapy. Immunity. 2014;41(1):49\u201361.","journal-title":"Immunity"},{"key":"1400_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.566511","volume":"10","author":"I Larionova","year":"2020","unstructured":"Larionova I, Tuguzbaeva G, Ponomaryova A, et al. Tumor-associated macrophages in human breast, colorectal, lung ovarian and prostate cancers. Front Oncol. 2020;10: 566511.","journal-title":"Front Oncol"},{"issue":"6","key":"1400_CR32","doi-asserted-by":"publisher","first-page":"8509","DOI":"10.1002\/jcp.27782","volume":"234","author":"B Farhood","year":"2019","unstructured":"Farhood B, Najafi M, Mortezaee K. CD8(+) cytotoxic T lymphocytes in cancer immunotherapy: a review. J Cell Physiol. 2019;234(6):8509\u201321.","journal-title":"J Cell Physiol"},{"issue":"10","key":"1400_CR33","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/s41577-018-0044-0","volume":"18","author":"J Borst","year":"2018","unstructured":"Borst J, Ahrends T, B\u0105ba\u0142a N, et al. CD4(+) T cell help in cancer immunology and immunotherapy. Nat Rev Immunol. 2018;18(10):635\u201347.","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"1400_CR34","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.immuni.2019.12.007","volume":"52","author":"A Sledzinska","year":"2020","unstructured":"Sledzinska A, de Vila Mucha M, Bergerhoff K, et al. Regulatory T cells restrain interleukin-2- and blimp-1-dependent acquisition of cytotoxic function by CD4(+) T cells. Immunity. 2020;52(1):151\u201366.","journal-title":"Immunity"},{"issue":"9","key":"1400_CR35","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1113\/EP088627","volume":"105","author":"ED Hanson","year":"2020","unstructured":"Hanson ED, Sakkal S, Que S, et al. Natural killer cell mobilization and egress following acute exercise in men with prostate cancer. Exp Physiol. 2020;105(9):1524\u201339.","journal-title":"Exp Physiol"},{"key":"1400_CR36","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.SABCS19-P5-08-22","author":"LZG Cao","year":"2019","unstructured":"Cao LZG, Li X, Wang Y, Chen B, Guo L, Ren C, Li K, Li Z, Mok H, Wen L, Jia M, Wei G, Lin J, Liao N. Associations between MYC alterations and clinical pathological characteristics in Chinese patients and TCGA cohort. San Antonio Breast Cacner Symposium. 2019. https:\/\/doi.org\/10.1158\/1538-7445.SABCS19-P5-08-22.","journal-title":"San Antonio Breast Cacner Symposium."},{"issue":"1","key":"1400_CR37","doi-asserted-by":"publisher","first-page":"217","DOI":"10.3390\/ijms21010217","volume":"21","author":"E Katsuta","year":"2019","unstructured":"Katsuta E, Yan L, Takeshita T, et al. High MYC mRNA expression is more clinically relevant than MYC DNA amplification in triple-negative breast cancer. Int J Mol Sci. 2019;21(1):217.","journal-title":"Int J Mol Sci"},{"issue":"5","key":"1400_CR38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0216469","volume":"14","author":"Q Zhao","year":"2019","unstructured":"Zhao Q, Howard EW, Parris AB, et al. Bisphenol AF promotes estrogen receptor-positive breast cancer cell proliferation through amphiregulin-mediated crosstalk with receptor tyrosine kinase signaling. PLoS ONE. 2019;14(5): e0216469.","journal-title":"PLoS ONE"},{"issue":"1","key":"1400_CR39","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1186\/s12885-019-6483-6","volume":"19","author":"E Dagher","year":"2019","unstructured":"Dagher E, Royer V, Buchet P, et al. Androgen receptor and FOXA1 coexpression define a \u201cluminal-AR\u201d subtype of feline mammary carcinomas, spontaneous models of breast cancer. BMC Cancer. 2019;19(1):1267.","journal-title":"BMC Cancer"},{"issue":"2","key":"1400_CR40","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1158\/2159-8290.CD-18-1177","volume":"9","author":"AC Garrido-Castro","year":"2019","unstructured":"Garrido-Castro AC, Lin NU, Polyak K. Insights into molecular classifications of triple-negative breast cancer: improving patient selection for treatment. Cancer Discov. 2019;9(2):176\u201398.","journal-title":"Cancer Discov"},{"key":"1400_CR41","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.humpath.2020.06.002","volume":"102","author":"A Grabenstetter","year":"2020","unstructured":"Grabenstetter A, Mohanty AS, Rana S, et al. E-cadherin immunohistochemical expression in invasive lobular carcinoma of the breast: correlation with morphology and CDH1 somatic alterations. Hum Pathol. 2020;102:44\u201353.","journal-title":"Hum Pathol"},{"issue":"2","key":"1400_CR42","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1158\/1541-7786.MCR-17-0308","volume":"16","author":"G Brummer","year":"2018","unstructured":"Brummer G, Acevedo DS, Hu Q, et al. Chemokine signaling facilitates early-stage breast cancer survival and invasion through fibroblast-dependent mechanisms. Mol Cancer Res. 2018;16(2):296\u2013308.","journal-title":"Mol Cancer Res"},{"key":"1400_CR43","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.59893","author":"F Long","year":"2020","unstructured":"Long F, Lin H, Zhang X, et al. Atractylenolide-I suppresses tumorigenesis of breast cancer by inhibiting toll-like receptor 4-mediated nuclear factor-\u03baB signaling pathway. Front Pharmacol. 2020. https:\/\/doi.org\/10.3389\/fphar.2020.59893.","journal-title":"Front Pharmacol"},{"issue":"1","key":"1400_CR44","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.bbrc.2007.06.159","volume":"361","author":"Y Yamasaki","year":"2007","unstructured":"Yamasaki Y, Ito S, Tsunoda N, et al. SIRPalpha1 and SIRPalpha2: their role as tumor suppressors in breast carcinoma cells. Biochem Biophys Res Commun. 2007;361(1):7\u201313.","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"1400_CR45","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1038\/s41591-021-01323-8","volume":"27","author":"A Bassez","year":"2021","unstructured":"Bassez A, Vos H, Van Dyck L, et al. A single-cell map of intratumoral changes during anti-PD1 treatment of patients with breast cancer. Nat Med. 2021;27(5):820\u201332.","journal-title":"Nat Med"},{"issue":"1","key":"1400_CR46","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41523-021-00362-1","volume":"8","author":"S Loi","year":"2022","unstructured":"Loi S, Salgado R, Adams S, et al. Tumor infiltrating lymphocyte stratification of prognostic staging of early-stage triple negative breast cancer. NPJ Breast Cancer. 2022;8(1):3.","journal-title":"NPJ Breast Cancer"},{"issue":"1","key":"1400_CR47","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/S1470-2045(17)30904-X","volume":"19","author":"C Denkert","year":"2018","unstructured":"Denkert C, von Minckwitz G, Darb-Esfahani S, et al. Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy. Lancet Oncol. 2018;19(1):40\u201350.","journal-title":"Lancet Oncol"}],"container-title":["Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12282-022-01400-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12282-022-01400-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12282-022-01400-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T17:36:50Z","timestamp":1672853810000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12282-022-01400-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,21]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["1400"],"URL":"https:\/\/doi.org\/10.1007\/s12282-022-01400-x","relation":{},"ISSN":["1340-6868","1880-4233"],"issn-type":[{"value":"1340-6868","type":"print"},{"value":"1880-4233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,21]]},"assertion":[{"value":"8 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Yanhua Chen, Hongrui Li, and Wendy Wu are the employees of Berry Oncology Corporation. The other authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The present study was approved by the Ethics Committee at Guangdong Provincial People\u2019s Hospital (Nos. GDREC2014122H and GDREC2019497H).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The patient signed a written informed consent for participation.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The patient signed a written informed consent including the agreement for publication.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}